-
FDA Grants Orphan Drug Designation to FF-10832 for Biliary Tract Cancer
08 Jul 2025 19:48 GMT
… Receiving orphan drug designation highlights the significant unmet medical need that … cancer whose disease had progressed on gemcitabine plus cisplatin … drug designation for the treatment of biliary tract cancer. News release. FUJIFILM Pharmaceuticals …
-
Sound Pharma to Present at Upcoming Life Sciences Industry Conferences
08 Jul 2025 12:56 GMT
Sound Pharmaceuticals is pleased to … insults such as noise, ototoxic drugs, or aging. Consequently, … chemotherapy (such as cisplatin or carboplatin). To date, no significant drug-drug … year.
About Sound Pharmaceuticals
Sound Pharma is a private biotechnology …
-
Regulatory Role and Mechanism of lncRNA RNF217-AS1 in the Proliferation and Migration of Esophageal Cancer Cells
07 Jul 2025 11:54 GMT
… enhances the chemosensitivity of esophageal cancer cells to cisplatin, with glutaminase … Hebei University of Chinese Medicine. Consent to participate … in its management. Biomed Pharmacothe. 2023;165:115183. doi … 47;HOXA1 axis. Anti-Cancer Drugs. 2023;34(4):495– …
-
Paclitaxel Matches Cisplatin HIPEC in Ovarian Cancer
07 Jul 2025 08:57 GMT
… cancer undergoing interval cytoreductive surgery who received paclitaxel-based hyperthermic intraperitoneal chemotherapy … ] for advanced ovarian cancer. As cisplatin is the preferred drug according to strong …
-
Zanidatamab Combo Has Meaningful Activity in HER2+ Gastroesophageal Cancer
05 Jul 2025 22:59 GMT
… of Gastrointestinal Medical Oncology at Princess Margaret Cancer Centre in … -fluorouracil (5-FU) plus cisplatin (FP), or leucovorin plus 5 … ) plus combination chemotherapy in HER2-expressing gastrointestinal cancers, including gastroesophageal adenocarcinoma …
-
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer
05 Jul 2025 04:04 GMT
… invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as … -care neoadjuvant chemotherapy.
Dr Michiel Van der Heijden, medical oncologist and … and gastroesophageal junction cancers.
Imfinzi in combination with chemotherapy followed by …
-
Adding Imfinzi to FLOT Regimen Improves Cancer-Free Survival in Patients with Gastroesophageal Cancer
04 Jul 2025 18:29 GMT
… a chemotherapy regimen called FLOT. It includes the drugs 5 … invasive bladder cancer in combination with gemcitabine and cisplatin as … D., chief of gastrointestinal medical oncology at Memorial Sloan … New England Journal of Medicine (NEJM) and presented …
-
AZ claims EU okay for Imfinzi in bladder cancer
04 Jul 2025 12:48 GMT
… invasive bladder cancer (MIBC), given in combination with platinum chemotherapy before … the New England Journal of Medicine (NEJM).
In NIAGARA, patients … or refuse to take cisplatin and NILE as a … 39;s anti-Nectin-4 drug Padcev (enfortumab vedotin), which …
-
AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer
04 Jul 2025 15:49 GMT
… -invasive bladder cancer (MIBC) in combination with chemotherapy drugs gemcitabine and cisplatin as neoadjuvant … now open for the prestigious Pharmaceutical Technology Excellence Awards - one …
-
Imfinzi approved in the EU as first and only perioperative immunotherapy for muscle-invasive bladder cancer
04 Jul 2025 08:08 GMT
… invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant … care neoadjuvant chemotherapy.2
Dr Michiel Van der Heijden, medical oncologist and … Group Leader at the Netherlands Cancer Institute, …